AKORN FDA Approval ANDA 207692

ANDA 207692

AKORN

FDA Drug Application

Application #207692

Application Sponsors

ANDA 207692AKORN

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS0.005MG/ML (0.005MG/ML)0PARICALCITOLPARICALCITOL

FDA Submissions

UNKNOWN; ORIG1AP2017-10-16STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207692
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"PARICALCITOL","activeIngredients":"PARICALCITOL","strength":"0.005MG\/ML (0.005MG\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/16\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-10-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.